Group

The Immunoassay Market is undergoing a significant transformation with the rapid growth of point-of-care (PoC) testing. Historically, immunoassays were performed exclusively in centralized clinical laboratories, but technological advancements have enabled the development of portable, rapid, and easy-to-use testing devices. This shift has revolutionized diagnostic workflows, allowing for immediate results and faster clinical decision-making in a variety of settings, including physician offices, emergency rooms, and even a patient’s home. The convenience and speed of PoC immunoassays are particularly valuable in the diagnosis of infectious diseases, where a quick result can be crucial for initiating treatment and preventing transmission. The market for PoC immunoassay devices is expanding rapidly, driven by the demand for decentralized testing and a growing emphasis on patient convenience. While PoC devices are generally less sensitive than their lab-based counterparts, their ability to deliver results in minutes rather than hours or days makes them an indispensable tool in modern healthcare. The market for these devices is a key growth area, attracting both established diagnostic companies and new entrants. This trend is democratizing diagnostic testing and making it more accessible to a wider population. For a detailed breakdown of this market segment and the latest innovations in PoC technology, you can refer to the comprehensive Immunoassay Market report.